Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael H Davidson

Showing results (21-30 of 300) with videos related to

Pageof 30
Sort By:
Cardiovascular Drugs and Therapy|May 13, 2009
Pharmacological approaches to modifying HDL: more basic science to understand HDL metabolism is necessary. Editorial to: "NO-1886 up-regulates Niemann-Pick C1 protein (NPC1) expression through liver X receptor alpha signaling pathway in THP-1 macrophage-derived foam cells" by Xin Ma et alMichael H Davidson
Indian Heart Journal|December 10, 2016
Intensive statin therapy in India: Demonstrating efficacy and safetyMichael H Davidson
JAMA|January 6, 2005
High-dose statins in acute coronary syndromesMichael H Davidson
Circulation|May 11, 2005
Clinical significance of statin pleiotropic effects: hypotheses versus evidenceMichael H Davidson
Expert Opinion on Drug Safety|October 27, 2004
Rosuvastatin safety: lessons from the FDA review and post-approval surveillanceMichael H Davidson
The American Journal of Cardiology|August 22, 2006
Mechanisms for the hypotriglyceridemic effect of marine omega-3 fatty acidsMichael H Davidson
Current Atherosclerosis Reports|December 16, 2006
The FIELD Study and reduction of cardiovascular events in patients with diabetesMichael H Davidson
Current Atherosclerosis Reports|December 17, 2008
Novel nonstatin strategies to lower low-density lipoprotein cholesterolMichael H Davidson
The American Heart Hospital Journal|November 6, 2007
Targeting high-density lipoprotein cholesterol in the management of cardiovascular diseaseMichael H Davidson
Postgraduate Medicine|June 12, 2014
Potential impact of dipeptidyl peptidase-4 inhibitors on cardiovascular pathophysiology in type 2 diabetes mellitusMichael H Davidson
Pageof 30

Showing results (21-30 of 300) with videos related to

Sort By:
Pageof 30
Cardiovascular Drugs and Therapy|May 13, 2009
Pharmacological approaches to modifying HDL: more basic science to understand HDL metabolism is necessary. Editorial to: "NO-1886 up-regulates Niemann-Pick C1 protein (NPC1) expression through liver X receptor alpha signaling pathway in THP-1 macrophage-derived foam cells" by Xin Ma et alMichael H Davidson
Indian Heart Journal|December 10, 2016
Intensive statin therapy in India: Demonstrating efficacy and safetyMichael H Davidson
JAMA|January 6, 2005
High-dose statins in acute coronary syndromesMichael H Davidson
Circulation|May 11, 2005
Clinical significance of statin pleiotropic effects: hypotheses versus evidenceMichael H Davidson
Expert Opinion on Drug Safety|October 27, 2004
Rosuvastatin safety: lessons from the FDA review and post-approval surveillanceMichael H Davidson
The American Journal of Cardiology|August 22, 2006
Mechanisms for the hypotriglyceridemic effect of marine omega-3 fatty acidsMichael H Davidson
Current Atherosclerosis Reports|December 16, 2006
The FIELD Study and reduction of cardiovascular events in patients with diabetesMichael H Davidson
Current Atherosclerosis Reports|December 17, 2008
Novel nonstatin strategies to lower low-density lipoprotein cholesterolMichael H Davidson
The American Heart Hospital Journal|November 6, 2007
Targeting high-density lipoprotein cholesterol in the management of cardiovascular diseaseMichael H Davidson
Postgraduate Medicine|June 12, 2014
Potential impact of dipeptidyl peptidase-4 inhibitors on cardiovascular pathophysiology in type 2 diabetes mellitusMichael H Davidson
Pageof 30